Genpact (NYSE:G - Get Free Report)'s stock had its "buy" rating reaffirmed by equities researchers at Needham & Company LLC in a report released on Friday,Benzinga reports. They presently have a $50.00 price target on the business services provider's stock. Needham & Company LLC's price objective would suggest a potential upside of 57.08% from the company's previous close.
A number of other equities research analysts have also issued reports on the stock. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a research note on Saturday, March 14th. Mizuho reduced their price objective on shares of Genpact from $51.00 to $49.00 and set a "neutral" rating for the company in a research note on Tuesday, February 10th. Citigroup raised shares of Genpact from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 13th. Finally, Susquehanna reduced their price objective on shares of Genpact from $42.00 to $37.00 and set a "neutral" rating for the company in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Genpact has an average rating of "Hold" and an average target price of $46.00.
View Our Latest Report on G
Genpact Stock Down 7.7%
Shares of NYSE:G traded down $2.65 during trading on Friday, reaching $31.83. 3,323,748 shares of the company traded hands, compared to its average volume of 2,372,220. The firm has a fifty day simple moving average of $37.28 and a 200 day simple moving average of $41.35. The firm has a market cap of $5.40 billion, a P/E ratio of 10.17, a price-to-earnings-growth ratio of 0.99 and a beta of 0.61. Genpact has a 1-year low of $31.47 and a 1-year high of $48.64. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.46.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, May 7th. The business services provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.05. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.29 billion. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The company's revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the business posted $0.84 EPS. Genpact has set its Q2 2026 guidance at 0.960-0.970 EPS. Analysts anticipate that Genpact will post 3.6 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $40.77, for a total transaction of $114,156.00. Following the completion of the transaction, the chief executive officer owned 525,007 shares of the company's stock, valued at $21,404,535.39. The trade was a 0.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.58% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Genpact
Institutional investors have recently made changes to their positions in the business. Principal Financial Group Inc. increased its stake in shares of Genpact by 36.3% in the third quarter. Principal Financial Group Inc. now owns 497,105 shares of the business services provider's stock worth $20,824,000 after purchasing an additional 132,310 shares during the period. JPMorgan Chase & Co. raised its position in shares of Genpact by 17.1% during the third quarter. JPMorgan Chase & Co. now owns 3,762,407 shares of the business services provider's stock valued at $157,609,000 after buying an additional 549,117 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of Genpact by 64.3% during the third quarter. Envestnet Asset Management Inc. now owns 533,566 shares of the business services provider's stock valued at $22,351,000 after buying an additional 208,762 shares during the last quarter. ProShare Advisors LLC raised its position in shares of Genpact by 27.5% during the third quarter. ProShare Advisors LLC now owns 153,260 shares of the business services provider's stock valued at $6,420,000 after buying an additional 33,056 shares during the last quarter. Finally, Allianz Asset Management GmbH raised its position in shares of Genpact by 153.6% during the third quarter. Allianz Asset Management GmbH now owns 1,597,446 shares of the business services provider's stock valued at $66,917,000 after buying an additional 967,559 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors.
Genpact Company Profile
(
Get Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report